Can a weight loss and diabetes drug treat long COVID?

Scripps Research in La Jolla announce a new clinical trial that will assess the effectiveness of using drugs approved for diabetes treatment and weight loss to treat long COVID-19, the debilitating chronic condition diagnosed in an estimated 20 million Americans and about 400 million people worldwide.

This article was originally published on MedicalXpress.com

You may also be interested in:

Read More:

Lawyers Lookup